Innova Captab

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0DUT01020
NSEID: INNOVACAP
BSEID: 544067
View on NSE | View on BSE

INR

713.55

-0.4 (-0.06%)

BSENSE

Mar 13

BSE+NSE Vol: 36.16 k

{
  "main_header": {
    "sid": 10039112,
    "name": "Innova Captab",
    "stock_name": "Innova Captab",
    "full_name": "Innova Captab Ltd",
    "name_url": "stocks-analysis/innova-captab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "713.55",
    "chg": -0.4,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "713.95",
    "mcapval": "4,132.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544067",
    "symbol": "INNOVACAP",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0DUT01020",
    "curr_date": "Mar 13",
    "curr_time": "",
    "bse_nse_vol": "36.16 k",
    "exc_status": "Active",
    "traded_date": "Mar 13, 2026",
    "traded_date_str": "2026 03 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/innova-captab-10039112-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3879220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/InnovaCaptabLtd_mojoScore_3879220.png",
        "date": "2026-03-09 10:10:02",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook."
      },
      {
        "title": "Innova Captab Ltd Falls to 52-Week Low of Rs.608.25 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-falls-to-52-week-low-of-rs60825-amidst-continued-downtrend-3865021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/InnovaCaptabLtd_priceRelatedfactors_3865021.png",
        "date": "2026-03-02 13:13:20",
        "description": "Innova Captab Ltd’s stock reached a fresh 52-week low of Rs.608.25 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind sector peers and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3857891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_mojoScore_3857891.png",
        "date": "2026-02-26 10:10:03",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3840967",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_mojoScore_3840967.png",
        "date": "2026-02-15 10:10:07",
        "description": "Innova Captab Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3820454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_mojoScore_3820454.png",
        "date": "2026-02-04 10:10:04",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Innova Captab Ltd Shows Mild Recovery Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-shows-mild-recovery-amid-mixed-technical-signals-3817324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_technicaldot_3817324.png",
        "date": "2026-02-03 08:05:41",
        "description": "Innova Captab Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day change of 0.10%, the stock’s technical indicators reveal a complex picture of price momentum and trend signals that investors should carefully analyse amid broader market conditions."
      },
      {
        "title": "Innova Captab Ltd Reports Strong Quarterly Turnaround Amid Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-reports-strong-quarterly-turnaround-amid-challenging-market-conditions-3804868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptabLtd_fintrenddot_3804868.png",
        "date": "2026-01-27 08:00:24",
        "description": "Innova Captab Ltd has delivered a remarkable turnaround in its financial performance for the quarter ended December 2025, reversing a negative trend seen over recent months. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics, signalling a positive shift in operational momentum despite lingering challenges in return ratios and long-term stock performance."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3803154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptabLtd_mojoScore_3803154.png",
        "date": "2026-01-24 10:10:03",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Innova Captab Gains 0.65%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-gains-065-4-key-factors-driving-the-weeks-volatility-3802855",
        "imagepath": "",
        "date": "2026-01-24 10:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Stock hits 52-week low of Rs.625 amid downtrend</p>\n                    <p><strong>Jan 19:</strong> Intraday high surge of 7.14% to Rs.739.35</p>\n                    <p><strong>Jan 23:</strong> Intraday high with 12.48% surge to Rs.730</p>\n                    <p><strong>Jan 23:</strong> Q3 FY26 results show strong revenue growth but margin pressures</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.649.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.678.40</div><d..."
      }
    ],
    "total": 491,
    "sid": "10039112",
    "stock_news_url": "https://www.marketsmojo.com/news/innova-captab-10039112"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Innova Captab Ltd has declared <strong>20%</strong> dividend, ex-date: 30 Jan 26",
          "dt": "2026-01-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Innova Captab Ltd is Rated Sell

2026-03-09 10:10:02

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook.

Read full news article

Innova Captab Ltd Falls to 52-Week Low of Rs.608.25 Amidst Continued Downtrend

2026-03-02 13:13:20

Innova Captab Ltd’s stock reached a fresh 52-week low of Rs.608.25 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind sector peers and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read full news article

Innova Captab Ltd is Rated Sell

2026-02-26 10:10:03

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Read full news article

Innova Captab Ltd is Rated Sell

2026-02-15 10:10:07

Innova Captab Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Innova Captab Ltd is Rated Sell

2026-02-04 10:10:04

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Innova Captab Ltd Shows Mild Recovery Amid Mixed Technical Signals

2026-02-03 08:05:41

Innova Captab Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day change of 0.10%, the stock’s technical indicators reveal a complex picture of price momentum and trend signals that investors should carefully analyse amid broader market conditions.

Read full news article

Innova Captab Ltd Reports Strong Quarterly Turnaround Amid Challenging Market Conditions

2026-01-27 08:00:24

Innova Captab Ltd has delivered a remarkable turnaround in its financial performance for the quarter ended December 2025, reversing a negative trend seen over recent months. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics, signalling a positive shift in operational momentum despite lingering challenges in return ratios and long-term stock performance.

Read full news article

Innova Captab Ltd is Rated Sell

2026-01-24 10:10:03

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook.